Literature DB >> 16424180

CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity.

Yoshihiro Hayakawa1, Mark J Smyth.   

Abstract

Lineage differentiation and the formation of heterogeneous mature subsets are crucial for immune cells to maintain a breadth of responsiveness to pathogens while controlling reactivity to self. In this study, we report that CD27 is a key marker of the NK cell lineage, dissecting the mature Mac-1high NK cell pool into two functionally distinct subsets. The CD27low NK cell subset possesses a higher threshold to stimulation and appears to be tightly regulated by the expression of NK cell inhibitory receptors. Comparatively, the CD27high NK cell subset displays a greater effector function, exhibits a distinct tissue distribution and responsiveness to chemokines, and interacts productively with dendritic cells. Importantly, we have verified that CD27high and CD27low subsets with distinct cell surface phenotypes also exist in human peripheral blood. These findings clearly reclassify mature NK cells into two distinct subsets and begin to discern their specific role in immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16424180     DOI: 10.4049/jimmunol.176.3.1517

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  315 in total

1.  Intact NKG2D-independent function of NK cells chronically stimulated with the NKG2D ligand Rae-1.

Authors:  Marine Champsaur; Joshua N Beilke; Kouetsu Ogasawara; Ulrich H Koszinowski; Stipan Jonjic; Lewis L Lanier
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Resident peritoneal NK cells.

Authors:  Rosemary Gonzaga; Polly Matzinger; Ainhoa Perez-Diez
Journal:  J Immunol       Date:  2011-11-11       Impact factor: 5.422

3.  NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation.

Authors:  Oliver Haworth; Manuela Cernadas; Bruce D Levy
Journal:  J Immunol       Date:  2011-04-22       Impact factor: 5.422

4.  Differential effects of stimulatory factors on natural killer cell activities of young and aged mice.

Authors:  Shoko Nogusa; Donna M Murasko; Elizabeth M Gardner
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-27       Impact factor: 6.053

5.  Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection.

Authors:  Hailong Guo; David J Topham
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

6.  The genetic background influences the cellular and humoral immune responses to vaccines.

Authors:  M Zeng; E Nourishirazi; E Guinet; M Nouri-Shirazi
Journal:  Clin Exp Immunol       Date:  2016-08-16       Impact factor: 4.330

7.  NK cells link obesity-induced adipose stress to inflammation and insulin resistance.

Authors:  Felix M Wensveen; Vedrana Jelenčić; Sonja Valentić; Marko Šestan; Tamara Turk Wensveen; Sebastian Theurich; Ariella Glasner; Davor Mendrila; Davor Štimac; F Thomas Wunderlich; Jens C Brüning; Ofer Mandelboim; Bojan Polić
Journal:  Nat Immunol       Date:  2015-03-02       Impact factor: 25.606

8.  Mouse natural killer cell development and maturation are differentially regulated by SHIP-1.

Authors:  Cindy Banh; S M Shahjahan Miah; William G Kerr; Laurent Brossay
Journal:  Blood       Date:  2012-10-03       Impact factor: 22.113

Review 9.  Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned.

Authors:  Jeanette E Boudreau; Katharine C Hsu
Journal:  Trends Immunol       Date:  2018-01-31       Impact factor: 16.687

10.  Transcription factor Foxo1 is a negative regulator of natural killer cell maturation and function.

Authors:  Youcai Deng; Yann Kerdiles; Jianhong Chu; Shunzong Yuan; Youwei Wang; Xilin Chen; Hsiaoyin Mao; Lingling Zhang; Jianying Zhang; Tiffany Hughes; Yafei Deng; Qi Zhang; Fangjie Wang; Xianghong Zou; Chang-Gong Liu; Aharon G Freud; Xiaohui Li; Michael A Caligiuri; Eric Vivier; Jianhua Yu
Journal:  Immunity       Date:  2015-03-10       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.